Published in Medical Device Law Weekly, March 4th, 2007
The notes offering is part of a previously announced refinancing of the company's existing $750 million syndicated bank credit facility.
The company intends to use the net proceeds of both the notes offering and the new revolving credit facility to repay in full its $250 million term loan and the outstanding borrowings under its existing syndicated bank credit facility.
The notes are not being registered under the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.